This 360 degree view shows staff at the University of Colorado Heart and Vascular Center performing live transesophageal ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
A discussion with Ruth Fisher, MBA, vice president of the Henry Ford Hospital structural heart program, and Janet Wyman ...
Marvin Eng, M.D., structural fellowship director at Henry Ford Health System, and William O'Neill, M.D., director of the ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
A discussion with William O’Neill, M.D., director of the Henry Ford structural heart program, Ruth Fisher, MBA, vice ...
September 30, 2019 – The first randomized trial to compare a durable polymer drug-eluting stent to a polymer-free drug ...
September 30, 2019 — A biodegradable polymer everolimus-eluting stent (BP-EES) followed by four months of dual ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
September 30, 2019 – Data from the EVOLVE Short DAPT study found that shortened three-month dual antiplatelet therapy ...
A discussion with Nicolas Bevins, Ph.D., vice chair, physics and research, and Jessica Harrington, RCIS. They explain ...
September 27, 2019 — Ancora Heart Inc. announced results from an interim analysis of heart failure patients treated in ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
September 27, 2019 — Abiomed’s newest heart pump, the Impella 5.5 with SmartAssist, has received U.S. Food and Drug ...
September 27, 2019 — EchoPixel introduced what it calls the first-ever intraoperative software to provide naked-eye ...
September 26, 2019 — New data from the Phase IV independent TWILIGHT trial showed Brilinta (ticagrelor) monotherapy redu ...
During cardiology fellowship, my institution had a hand manifold system. I found it difficult to use at times, and it ...
September 25, 2019 — Ten-year survival rates are similar for bypass surgery and coronary stenting with drug-eluting ...
September 24, 2019 – Medtronic announced U.S. Food and Drug Administration (FDA) approval and U.S. launch of the Evolut ...
There was a 77 percent increase in survival in cardiogenic shock patients treated using a new protocol in the National ...
October 02, 2019